These findings showed that high expression levels of KDM5A were significantly correlated with cancer stage and age (Fig. 2A, B), whereas high expression levels of KDM5B were significantly associated with tumor grade, cancer stage and TP53 mutations (Fig. 2C–E). This evidence concerns the gene KDM5B and neoplasm.